DOI: 10.1016/s0140-6736(85)91353-4. PHYSOSTIGMINE CONCENTRATIONS AFTER ORAL DOSES

PHYSOSTIGMINE CONCENTRATIONS AFTER ORAL DOSES

10.1016/s0140-6736(85)91353-4

Crossref journal-article

Elsevier BV

The Lancet (78)

Bibliography

Gibson, M., Moore, T., Smith, C., & Whelpton, R. (1985). PHYSOSTIGMINE CONCENTRATIONS AFTER ORAL DOSES. The Lancet, 325(8430), 695â696.

Authors 4

Mark Gibson (first)
Thomas Moore (additional)
ChristineM Smith (additional)
Robin Whelpton (additional)

References 6 Referenced 17

10.1002/ana.410030602 / Ann Neurol / Possible biochemical basis of memory disorder in Alzheimer's disease by Smith (1978)
10.1002/ana.410130220 / Ann Neurol / No effect from double-blind trial of physostigmine and lecithin in Alzheimer's disease by Wettstein (1983)
10.1002/ana.410140616 / Ann Neurol / Lack of clinical efficacy of chronic oral physostigmine in Alzheimer's disease by Jotkowitz (1983)
10.1002/ana.410130504 / Ann Neurol / Oral physostigmine and lecithin improve memory in Alzheimer's disease by Thal (1983)
10.1016/S0378-4347(00)86122-8 / J Chromatog / Analysis of plasma physostigmine concentrations by liquid chromatography by Whelpton (1983)
R. Whelpton, Pharmacokinetics of physostigmine: Preliminary results, Interdiscipl Topics Gerontol ((in press)). (10.1159/000410628)

Dates

Type	When
Created	21 years, 10 months ago (Oct. 11, 2003, 7 a.m.)
Deposited	7 years, 2 months ago (June 13, 2018, 10:47 p.m.)
Indexed	1 year, 10 months ago (Oct. 22, 2023, 2:17 a.m.)
Issued	40 years, 6 months ago (March 1, 1985)
Published	40 years, 6 months ago (March 1, 1985)
Published Print	40 years, 6 months ago (March 1, 1985)

Funders 0

None

BibTeX

@article{Gibson_1985, title={PHYSOSTIGMINE CONCENTRATIONS AFTER ORAL DOSES}, volume={325}, ISSN={0140-6736}, url={http://dx.doi.org/10.1016/s0140-6736(85)91353-4}, DOI={10.1016/s0140-6736(85)91353-4}, number={8430}, journal={The Lancet}, publisher={Elsevier BV}, author={Gibson, Mark and Moore, Thomas and Smith, ChristineM and Whelpton, Robin}, year={1985}, month=mar, pages={695–696} }

JSON

{
  "indexed": {
    "date-parts": [
      [
        2023,
        10,
        22
      ]
    ],
    "date-time": "2023-10-22T06:17:44Z",
    "timestamp": 1697955464174
  },
  "reference-count": 6,
  "publisher": "Elsevier BV",
  "issue": "8430",
  "license": [
    {
      "start": {
        "date-parts": [
          [
            1985,
            3,
            1
          ]
        ],
        "date-time": "1985-03-01T00:00:00Z",
        "timestamp": 478483200000
      },
      "content-version": "tdm",
      "delay-in-days": 0,
      "URL": "https://www.elsevier.com/tdm/userlicense/1.0/"
    }
  ],
  "content-domain": {
    "domain": [],
    "crossmark-restriction": false
  },
  "published-print": {
    "date-parts": [
      [
        1985,
        3
      ]
    ]
  },
  "DOI": "10.1016/s0140-6736(85)91353-4",
  "type": "journal-article",
  "created": {
    "date-parts": [
      [
        2003,
        10,
        11
      ]
    ],
    "date-time": "2003-10-11T11:00:29Z",
    "timestamp": 1065870029000
  },
  "page": "695-696",
  "source": "Crossref",
  "is-referenced-by-count": 17,
  "title": "PHYSOSTIGMINE CONCENTRATIONS AFTER ORAL DOSES",
  "prefix": "10.1016",
  "volume": "325",
  "author": [
    {
      "given": "Mark",
      "family": "Gibson",
      "sequence": "first",
      "affiliation": []
    },
    {
      "given": "Thomas",
      "family": "Moore",
      "sequence": "additional",
      "affiliation": []
    },
    {
      "given": "ChristineM",
      "family": "Smith",
      "sequence": "additional",
      "affiliation": []
    },
    {
      "given": "Robin",
      "family": "Whelpton",
      "sequence": "additional",
      "affiliation": []
    }
  ],
  "member": "78",
  "reference": [
    {
      "key": "10.1016/S0140-6736(85)91353-4_BIB1",
      "doi-asserted-by": "crossref",
      "first-page": "471",
      "DOI": "10.1002/ana.410030602",
      "article-title": "Possible biochemical basis of memory disorder in Alzheimer's disease",
      "volume": "3",
      "author": "Smith",
      "year": "1978",
      "journal-title": "Ann Neurol"
    },
    {
      "key": "10.1016/S0140-6736(85)91353-4_BIB2",
      "doi-asserted-by": "crossref",
      "first-page": "210",
      "DOI": "10.1002/ana.410130220",
      "article-title": "No effect from double-blind trial of physostigmine and lecithin in Alzheimer's disease",
      "volume": "13",
      "author": "Wettstein",
      "year": "1983",
      "journal-title": "Ann Neurol"
    },
    {
      "key": "10.1016/S0140-6736(85)91353-4_BIB3",
      "doi-asserted-by": "crossref",
      "first-page": "690",
      "DOI": "10.1002/ana.410140616",
      "article-title": "Lack of clinical efficacy of chronic oral physostigmine in Alzheimer's disease",
      "volume": "14",
      "author": "Jotkowitz",
      "year": "1983",
      "journal-title": "Ann Neurol"
    },
    {
      "key": "10.1016/S0140-6736(85)91353-4_BIB4",
      "doi-asserted-by": "crossref",
      "first-page": "491",
      "DOI": "10.1002/ana.410130504",
      "article-title": "Oral physostigmine and lecithin improve memory in Alzheimer's disease",
      "volume": "13",
      "author": "Thal",
      "year": "1983",
      "journal-title": "Ann Neurol"
    },
    {
      "key": "10.1016/S0140-6736(85)91353-4_BIB5",
      "doi-asserted-by": "crossref",
      "first-page": "216",
      "DOI": "10.1016/S0378-4347(00)86122-8",
      "article-title": "Analysis of plasma physostigmine concentrations by liquid chromatography",
      "volume": "272",
      "author": "Whelpton",
      "year": "1983",
      "journal-title": "J Chromatog"
    },
    {
      "key": "10.1016/S0140-6736(85)91353-4_BIB6",
      "doi-asserted-by": "crossref",
      "unstructured": "R. Whelpton, Pharmacokinetics of physostigmine: Preliminary results, Interdiscipl Topics Gerontol ((in press)).",
      "DOI": "10.1159/000410628"
    }
  ],
  "container-title": "The Lancet",
  "original-title": [],
  "language": "en",
  "link": [
    {
      "URL": "https://api.elsevier.com/content/article/PII:S0140673685913534?httpAccept=text/xml",
      "content-type": "text/xml",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://api.elsevier.com/content/article/PII:S0140673685913534?httpAccept=text/plain",
      "content-type": "text/plain",
      "content-version": "vor",
      "intended-application": "text-mining"
    }
  ],
  "deposited": {
    "date-parts": [
      [
        2018,
        6,
        14
      ]
    ],
    "date-time": "2018-06-14T02:47:08Z",
    "timestamp": 1528944428000
  },
  "score": 1,
  "resource": {
    "primary": {
      "URL": "https://linkinghub.elsevier.com/retrieve/pii/S0140673685913534"
    }
  },
  "subtitle": [],
  "short-title": [],
  "issued": {
    "date-parts": [
      [
        1985,
        3
      ]
    ]
  },
  "references-count": 6,
  "journal-issue": {
    "issue": "8430",
    "published-print": {
      "date-parts": [
        [
          1985,
          3
        ]
      ]
    }
  },
  "alternative-id": [
    "S0140673685913534"
  ],
  "URL": "http://dx.doi.org/10.1016/S0140-6736(85)91353-4",
  "relation": {},
  "ISSN": [
    "0140-6736"
  ],
  "subject": [],
  "container-title-short": "The Lancet",
  "published": {
    "date-parts": [
      [
        1985,
        3
      ]
    ]
  }
}